scholarly article | Q13442814 |
P356 | DOI | 10.1055/S-0029-1243249 |
P698 | PubMed publication ID | 20013647 |
P50 | author | Mathias Fasshauer | Q64495185 |
Matthias Blüher | Q15431947 | ||
Michael Stumvoll | Q30434795 | ||
P2093 | author name string | A Bachmann | |
U Lössner | |||
M Reiche | |||
P433 | issue | 3 | |
P304 | page(s) | 178-181 | |
P577 | publication date | 2009-12-14 | |
P1433 | published in | Hormone and Metabolic Research | Q15758682 |
P1476 | title | Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters | |
P478 | volume | 42 |
Q38977291 | Cardiac actions of fibroblast growth factor 23. |
Q26781556 | Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy |
Q36778095 | Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression |
Q24629260 | Endocrine fibroblast growth factors 15/19 and 21: from feast to famine |
Q42789527 | FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway |
Q38889597 | FGF19 promotes progression of prostate cancer |
Q92710707 | FGF19 subfamily members: FGF19 and FGF21 |
Q42920547 | Fibroblast growth factor 19 entry into brain |
Q35020888 | Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease |
Q37781747 | Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease |
Q36281648 | Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery |
Q44427743 | Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. |
Q97643831 | Metabolic Messengers: fibroblast growth factor 15/19 |
Q36107291 | Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases |
Q55345479 | Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. |
Q34469627 | Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application |
Q28070054 | Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state |
Q35049496 | Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history |
Q34938380 | Serum levels of fibroblast growth factor 19 are inversely associated with coronary artery disease in chinese individuals |
Q30234616 | The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes |
Q38633258 | Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. |
Search more.